AUG 30, 2015 2:49 PM PDT

Cancer Models

WRITTEN BY: Ilene Schneider
While mathematical models are powerful tools for demonstrating how cancer grows and spreads, they have an either/or problem, according to scientists at Harvard University

Harvard researchers combine mathematical and spatial models of cancer. 
Models that capture the spatial, or 3-D, aspects of tumors do not reflect their growth speed. Non-spatial models portray the growth of tumors accurately, but not their 3-D nature. The Harvard scientists wanted to unite the two.
 
A team led by Martin Nowak, director of the Program for Evolutionary Dynamics and a professor of mathematics and of biology, has developed the first model of solid tumor growth that reflects both shape and growth. The study is described in the journal Nature and in Drug Discovery & Development
 
As Nowak explained, “Previously, we and many other people used non-spatial models, but those models couldn’t possibly explain how a solid tumor could arise. Now, for the first time, we have a spatial model that can do that.”
 
The new model is different. It enables cells to migrate locally and answers critical questions about the proximity of different cells to one another.
 
Nowak said, “That is what makes cancers grow fast, and it’s what makes cancers homogenous in the sense that cancer cells share a common set of mutations, and what is responsible for the rapid evolution of drug resistance. I further believe that the ability to form metastases, which is what actually kills patients, is a consequence of the selection for local migration. The majority of the mathematical models in the past started with a population of cells, and they would simply count the number of mutations they had, but that’s ignoring the spatial structure, so it doesn’t ask which cell is close to another cell.”
 
He believes that understanding spatial structure is important, because of the role it plays in how tumors grow. Earlier spatial models, conceived with the idea that tumor cells would divide only if they had the necessary space, produced slower growth, because only the cells on the surface of the tumor could divide. When cells have the ability to migrate locally, “individual cells can always find new space where they can divide,” Nowak said. The result was a model that demonstrates faster growth and explains why cancer cells share a high number of genetic mutations and how drug resistance can develop in tumors.
 
While all cells develop mutations as they divide, cancer cells have “driver” mutations — changes that enable cells to divide faster, live longer or resist drugs. They cause rapid tumor growth, carry forward passenger mutations and, thus have many mutations in common. Drug resistance happens when cells mutate to resist a particular treatment. Targeted therapies wipe out nearly all other cells, but the few resistant ones quickly replicate, causing a relapse.
 
Nowak concluded, “This migration ability helps to explain how driver mutations are able to dominate a tumor, and also explains why targeted therapies fail within a few months as resistance evolves. So what we have is a mathematical model for solid tumors, and it’s this local migration that explains these questions.”
 
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 16, 2020
Cancer
Does Discontinuation of Immunotherapy Effect Final Results in Metastatic Melanoma?
SEP 16, 2020
Does Discontinuation of Immunotherapy Effect Final Results in Metastatic Melanoma?
The last decade has seen the emergence of several new therapies against cancer. For melanoma, checkpoint inhibitors have ...
OCT 03, 2020
Cannabis Sciences
Cannabis Compound Prevents Colon Cancer in Mice
OCT 03, 2020
Cannabis Compound Prevents Colon Cancer in Mice
Second only to skin cancer, colon cancer is the most common cancer diagnosed in both men and women in the US. Now, resea ...
OCT 05, 2020
Health & Medicine
Cannabis Chemotherapy Trial Shows Encouraging Phase II Results
OCT 05, 2020
Cannabis Chemotherapy Trial Shows Encouraging Phase II Results
Even with the best anti-nausea medications one in three patients receiving chemotherapy experiences vomiting, and about ...
OCT 08, 2020
Immunology
Immuno Metabolic Complexity and Modulating Metabolites
OCT 08, 2020
Immuno Metabolic Complexity and Modulating Metabolites
Immunometabolism is a relatively new subspecialty of immunology as we’ve begun to unravel the complex metabolic re ...
NOV 20, 2020
Cancer
How does tissue geometry influence cancer cellular migration?
NOV 20, 2020
How does tissue geometry influence cancer cellular migration?
A team of researchers led by UC Santa Barbara's Distinguished Professor Denise Montell has recently published new fi ...
NOV 23, 2020
Cancer
Where are the geographic hotspots of high mortality rates for women with colorectal cancer?
NOV 23, 2020
Where are the geographic hotspots of high mortality rates for women with colorectal cancer?
A study published in Clinical and Translational Gastroenterology highlights the risk disparities in death rates fro ...
Loading Comments...